Another previous study corroborated our findings, which revealed that both METTL3 and CDCP1 were robustly expressed in bladder cancer, and also that the suppression of the METTL3-m6A-CDCP1 axis could restrict the bladder cancer growth and tumorigenesis both in vitro and in vivo [17]. Here, CDCP1 is linked to urinary bladder cancer.